The clinical administration of methylphenidate hydrochloride, widely recognized by its trade name Ritalin, stands as a critical pillar within contemporary psychopharmacology for treating attention-related conditions and narcolepsy. As medical science advances into 2026, healthcare systems across the United States, Canada, Brazil, Mexico, Australia, New Zealand, the United Kingdom, the Netherlands, Germany, and Switzerland continuously refine […]